中駿集團控股(01966.HK)進一步部分購回並註銷2022年到期優先票據
格隆匯2月25日丨中駿集團控股(01966.HK)公吿,於2022年2月24日至2022年2月25日期間,公司於公開巿場進一步購回本金總額2200萬美元的2022年票據,相當於原先發行2022年票據本金總額4.4%。購回的2022年票據將根據2022年票據的條款及條件註銷。
於公吿日期,公司已購回本金總額1.53億美元的2022年票據,相當於原先發行2022年票據本金總額30.6%。購回的2022年票據註銷後,尚未購回的2022年票據本金總額為3.47億美元,相當於原先發行2022年票據本金總額69.4%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.